Squarepoint
TSVT

Squarepoint’s 2seventy bio TSVT Stock Holding History

Squarepoint’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,164
Closed -$98.9K – 4622
2023
Q4 		$98.9K Sell
23,164
-28,527
-55% -$87.7K ﹤0.01% 3755
2023
Q3 		$203K Buy
+51,691
New +$339K ﹤0.01% 3402
2022
Q1 		– Sell
-8,165
Closed -$209K – 3539
2021
Q4 		$209K Buy
+8,165
New +$255K ﹤0.01% 2676

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Squarepoint's TSVT Position: Q1 2024 in Review

Squarepoint sold out of 2seventy bio (TSVT) in Q1 2024, closing a stake of 23,164 shares — an estimated $98.9K sold.

Squarepoint first reported a position in TSVT in Q4 2021 and held it in 3 quarters. The position peaked at $209K in Q4 2021. 117 funds tracked by Wall St. Rank hold TSVT as of Q1 2024.

  • Squarepoint reported no remaining 2seventy bio position as of Q1 2024 after selling out during the quarter.
  • Squarepoint sold 23,164 2seventy bio shares in Q1 2024, an estimated $98.9K.
  • Squarepoint first reported a position in 2seventy bio in Q4 2021 and held it in 3 quarters.
  • Squarepoint's 2seventy bio position peaked at $209K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.